COMMUNIQUÉS West-GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report
03/07/2026 -
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
02/07/2026 -
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
02/07/2026 -
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026
02/07/2026 -
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
02/07/2026 -
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
02/07/2026 -
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
02/07/2026 -
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
02/07/2026 -
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
02/07/2026 -
CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative
02/07/2026
Pages